Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Garcia

Showing results (281-290 of 317) with videos related to

Pageof 32
Sort By:
Blood Immunology & Cellular Therapy|April 17, 2026
Viral vector-free generation of orthogonal IL-2-responsive CAR T cells through gene editing of IL-2 and its receptorQian Zhang, Yihao Wu, Jingyi Yang, et al.
Cell|December 26, 2017
Antigen Identification for Orphan T Cell Receptors Expressed on Tumor-Infiltrating LymphocytesMarvin H Gee, Arnold Han, Shane M Lofgren, et al.
The Journal of Experimental Medicine|December 6, 2017
Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapyZinal S Chheda, Gary Kohanbash, Kaori Okada, et al.
Nature|September 16, 2021
An engineered IL-2 partial agonist promotes CD8<sup>+</sup> T cell stemnessFei Mo, Zhiya Yu, Peng Li, et al.
Cell|June 27, 2024
Preclinical proof of principle for orally delivered Th17 antagonist miniproteinsStephanie Berger, Franziska Seeger, Ta-Yi Yu, et al.
Nature|June 8, 2022
Potentiating adoptive cell therapy using synthetic IL-9 receptorsAnusha Kalbasi, Mikko Siurala, Leon L Su, et al.
Nature|November 15, 2022
Publisher Correction: Potentiating adoptive cell therapy using synthetic IL-9 receptorsAnusha Kalbasi, Mikko Siurala, Leon L Su, et al.
Nature|September 24, 2025
Design of facilitated dissociation enables timing of cytokine signallingAdam J Broerman, Christoph Pollmann, Yang Zhao, et al.
Science (New York, N.Y.)|March 19, 2026
Overcoming T cell tolerance to tumor self-antigens through catch-bond engineeringXiaojing Chen, Zhiyuan Mao, E Motunrayo Kolawole, et al.
Biorxiv : the Preprint Server for Biology|March 13, 2023
FOXP3<sup>+</sup> regulatory T cells use heparanase to access IL-2 bound to ECM in inflamed tissuesHunter A Martinez, Ievgen Koliesnik, Gernot Kaber, et al.
Pageof 32

Showing results (281-290 of 317) with videos related to

Sort By:
Pageof 32
Blood Immunology & Cellular Therapy|April 17, 2026
Viral vector-free generation of orthogonal IL-2-responsive CAR T cells through gene editing of IL-2 and its receptorQian Zhang, Yihao Wu, Jingyi Yang, et al.
Cell|December 26, 2017
Antigen Identification for Orphan T Cell Receptors Expressed on Tumor-Infiltrating LymphocytesMarvin H Gee, Arnold Han, Shane M Lofgren, et al.
The Journal of Experimental Medicine|December 6, 2017
Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapyZinal S Chheda, Gary Kohanbash, Kaori Okada, et al.
Nature|September 16, 2021
An engineered IL-2 partial agonist promotes CD8<sup>+</sup> T cell stemnessFei Mo, Zhiya Yu, Peng Li, et al.
Cell|June 27, 2024
Preclinical proof of principle for orally delivered Th17 antagonist miniproteinsStephanie Berger, Franziska Seeger, Ta-Yi Yu, et al.
Nature|June 8, 2022
Potentiating adoptive cell therapy using synthetic IL-9 receptorsAnusha Kalbasi, Mikko Siurala, Leon L Su, et al.
Nature|November 15, 2022
Publisher Correction: Potentiating adoptive cell therapy using synthetic IL-9 receptorsAnusha Kalbasi, Mikko Siurala, Leon L Su, et al.
Nature|September 24, 2025
Design of facilitated dissociation enables timing of cytokine signallingAdam J Broerman, Christoph Pollmann, Yang Zhao, et al.
Science (New York, N.Y.)|March 19, 2026
Overcoming T cell tolerance to tumor self-antigens through catch-bond engineeringXiaojing Chen, Zhiyuan Mao, E Motunrayo Kolawole, et al.
Biorxiv : the Preprint Server for Biology|March 13, 2023
FOXP3<sup>+</sup> regulatory T cells use heparanase to access IL-2 bound to ECM in inflamed tissuesHunter A Martinez, Ievgen Koliesnik, Gernot Kaber, et al.
Pageof 32